http://pn.psychiatryonline.org/cgi/content/short/41/15/1

Psychiatric Patients Win Medicare Part D Appeals
Mark Moran

During the course of evaluating Medicare Part D appeals, CMS clarifies
that a dosage higher than that approved by the FDA should not be
considered an off-label use and is thus not grounds to deny coverage.
At least two psychiatric patients have successfully appealed
medication denials under the Medicare Part D prescription drug program
resulting in policy changes by the Centers for Medicare and Medicaid
Services (CMS).


"People Who experience mood swings, fear, voices and visions"